A 15-year nationwide epidemiological analysis of Guillain-Barré syndrome in Taiwan

Neuroepidemiology

Volumn 44, Issue 4, 2015, Pages 249-254

  Huang, Wan Chun ^a   Lu, Chin Li ^b,c   Chen, Solomon Chih Cheng ^b,d,e  

^a Division of Pulmonary Medicine   (United States)

^b CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e NONE   (Taiwan)

Author keywords

Epidemiology; Guillain Barr syndrome; Incidence; Seasonal variation

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; AUTUMN; CHILD; CLINICAL FEATURE; DATA BASE; FEMALE; GUILLAIN BARRE SYNDROME; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; ICD-9-CM; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; NEWBORN; SEASONAL VARIATION; SPRING; SUMMER; TAIWAN; WINTER; AGE; GUILLAIN-BARRE SYNDROME; PRESCHOOL CHILD; SEASON; SEX DIFFERENCE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; SEASONS; SEX FACTORS; TAIWAN; YOUNG ADULT;

EID: 84931835237     PISSN: 02515350     EISSN: 14230208     Source Type: Journal    
DOI: 10.1159/000430917     Document Type: Article

References (30)

1. van Doorn PA, Ruts L, Jacobs BC: Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome. Lancet Neurol 2008; 7: 939-950.
2. Hughes RA, Cornblath DR: Guillain-Barré syndrome. Lancet 2005; 366: 1653-1666.
3. van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA: Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol 2014; 10: 469-482.
4. Yuki N, Hartung HP: Guillain-Barré syndrome. N Engl J Med 2012; 366: 2294-2304.
5. Guarino M, Casmiro M, D'Alessandro R: Campylobacter jejuni infection and Guillain-Barré syndrome: a case-control study. Emiliaromagna study group on clinical and epidemiological problems in neurology. Neuroepidemiology 1998; 17: 296-302.
6. Alter M: The epidemiology of Guillain-Barré syndrome. Ann Neurol 1990; 27(suppl):S7-S12.
7. Cheng BC, Chang WN, Chang CS, Chee CY, Huang CR, Chen JB, Chang CJ, Hung PL, Wang KW, Chang HW, Lu CH: Guillain-Barré syndrome in southern Taiwan: clinical features, prognostic factors and therapeutic outcomes. Eur J Neurol 2003; 10: 655-662.
8. Lyu RK, Tang LM, Cheng SY, Hsu WC, Chen ST: Guillain-Barré syndrome in Taiwan: a clinical study of 167 patients. J Neurol Neurosurg Psychiatry 1997; 63: 494-500.
9. Borhani Haghighi A, Banihashemi MA, Zamiri N, Sabayan B, Heydari ST, Safari A, Lankarani KB: Seasonal variation of Guillain-Barré syndrome admission in a large tertiary referral center in southern Iran: a 10 year analysis. Acta Neurol Taiwan 2012; 21: 60-63.
10. Hense S, Schink T, Kreisel SH, Marcelon L, Simondon F, Tahden M, Garbe E: Estimation of background incidence rates of Guillain-Barré syndrome in Germany - a retrospective cohort study with electronic healthcare data. Neuroepidemiology 2014; 43: 244-252.
11. Wise ME, Viray M, Sejvar JJ, Lewis P, Baughman AL, Connor W, Danila R, Giambrone GP, Hale C, Hogan BC, Meek JI, Murphree R, Oh JY, Reingold A, Tellman N, Conner SM, Singleton JA, Lu PJ, DeStefano F, Fridkin SK, Vellozzi C, Morgan OW: Guillain-Barre syndrome during the 2009-2010 H1N1 influenza vaccination campaign: population-based surveillance among 45 million americans. Am J Epidemiol 2012; 175: 1110-1119.
12. Stowe J, Andrews N, Wise L, Miller E: Investigation of the temporal association of Guillain-Barre syndrome with influenza vaccine and influenzalike illness using the United Kingdom general practice research database. Am J Epidemiol 2009; 169: 382-388.
13. Tam CC, O'Brien SJ, Petersen I, Islam A, Hayward A, Rodrigues LC: Guillain-Barré syndrome and preceding infection with campylobacter, influenza and Epstein-Barr virus in the general practice research database. PLoS One 2007; 2:e344.
14. Lasky T, Terracciano GJ, Magder L, Koski CL, Ballesteros M, Nash D, Clark S, Haber P, Stolley PD, Schonberger LB, Chen RT: The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines. N Engl J Med 1998; 339: 1797-1802.
15. Souayah N, Yacoub HA, Khan HM, Michas-Martin PA, Menkes DL, Maybodi L, Qureshi AI: Guillain-Barré syndrome after H1N1 vaccination in the United States: a report using the CDC/FDA vaccine adverse event reporting system (2009). Neuroepidemiology 2012; 38: 227-232.
16. Sejvar JJ, Baughman AL, Wise M, Morgan OW: Population incidence of Guillain-Barré syndrome: a systematic review and metaanalysis. Neuroepidemiology 2011; 36: 123-133.
17. Jiang GX, Cheng Q, Link H, de Pedro-Cuesta J: Epidemiological features of Guillain-Barré syndrome in Sweden, 1978-1993. J Neurol Neurosurg Psychiatry 1997; 62: 447-453.
18. Alshekhlee A, Hussain Z, Sultan B, Katirji B: Guillain-Barré syndrome: incidence and mortality rates in US hospitals. Neurology 2008; 70: 1608-1613.
19. Chen Y, Ma F, Zhang J, Chu X, Xu Y: Population incidence of Guillain-Barré syndrome in parts of China: three large populations in Jiangsu province, 2008-2010. Eur J Neurol 2014; 21: 124-129.
20. Cheng Q, Wang DS, Jiang GX, Han H, Zhang Y, Wang WZ, Fredrikson S: Distinct pattern of age-specific incidence of Guillain-Barré syndrome in Harbin, China. J Neurol 2002; 249: 25-32.
21. Meng Q, Tang S: Universal Coverage of Health Care in China: Challenges and Opportunities. World Health Report Background Paper, 2010. http://www.who.int/healthsystems/topics/financing/healthreport/7chinam-t.pdf.
22. McKhann GM, Cornblath DR, Griffin JW, Ho TW, Li CY, Jiang Z, Wu HS, Zhaori G, Liu Y, Jou LP, et al: Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol 1993; 33: 333-342.
23. McGrogan A, Madle GC, Seaman HE, de Vries CS: The epidemiology of Guillain-Barré syndrome worldwide. A systematic literature review. Neuroepidemiology 2009; 32: 150-163.
24. Shui IM, Rett MD, Weintraub E, Marcy M, Amato AA, Sheikh SI, Ho D, Lee GM, Yih WK; Vaccine Safety Datalink Research Team: Guillain-Barré syndrome incidence in a large United States cohort (2000-2009). Neuroepidemiology 2012; 39: 109-115.
25. Mathew T, Srinivas M, Nadig R, Arumugam R, Sarma GR: Seasonal and monthly trends in the occurrence of Guillain-Barre syndrome over a 5-year period: a tertiary care hospitalbased study from south India. Ann Indian Acad Neurol 2014; 17: 239-241.
26. Islam Z, Jacobs BC, van Belkum A, Mohammad QD, Islam MB, Herbrink P, Diorditsa S, Luby SP, Talukder KA, Endtz HP: Axonal variant of Guillain-Barre syndrome associated with campylobacter infection in Bangladesh. Neurology 2010; 74: 581-587.
27. Bogliun G, Beghi E; Guillain-Barrè Syndrome Registry Study Group: Validity of hospital discharge diagnoses for public health surveillance of the Guillain-Barrè syndrome. Neurol Sci 2002; 23: 113-117.
28. Koobatian TJ, Birkhead GS, Schramm MM, Vogt RL: The use of hospital discharge data for public health surveillance of Guillain-Barré syndrome. Ann Neurol 1991; 30: 618-621.
29. Shen CC, Tsai SJ, Perng CL, Kuo BI, Yang AC: Risk of Parkinson disease after depression: a nationwide population-based study. Neurology 2013; 81: 1538-1544.
30. Kang JH, Sheu JJ, Lin HC: Increased risk of Guillain-Barré syndrome following recent herpes zoster: a population-based study across Taiwan. Clin Infect Dis 2010; 51: 525-530.